The global Antihyperlipidemic Drugs Market is estimated to reach a value of US$ 12.6 Bn in 2022, with a projected CAGR of 7.5% during the forecast period of 2023-2030.
Antihyperlipidemic drugs are used to lower high levels of lipids (cholesterol and triglycerides) in the blood, reducing the risk of cardiovascular diseases. The market for these drugs is driven by the increasing ... Read more
Antihyperlipidemic drugs help lower levels of triglycerides and cholesterol in the bloodstream, reducing the risks of serious cardiovascular diseases. Statins are the most commonly prescribed antihyperlipidemic drugs, helping millions of people manage their lipid levels through inhibition of an enzyme involved in cholesterol biosynthesis. As awareness of the importance of balanced diet, regular exercise and cardiovascular health increases globally, demand for lipid-lowering agents ... Read more
